RONAK

Our History

Since 2001

2001

Foundation

Foundation of Rumik pharmaceutical company with aim of importing pharmaceutical supplements.

Started with a small team encompassing visionary leaders who saw the gap in the local market for high-quality supplements. Established key partnerships with European suppliers.

2002-2003

Expansion

Started importing medicines from reputable international companies.

Expanded the portfolio to include vital cardiovascular and diabetic medications. Secured exclusive distribution rights for 3 major global brands.

2004-2005

Growth

Establishment of Ronak Pharmaceutical Company.

Ronak Pharmaceutical was officially incorporated to consolidate operations and focus on manufacturing. Acquired land for the first production facility.

2006-2007

Production

Launching the first production line for solid dosage forms.

Commissioned the state-of-the-art solid dosage facility. First batch of generic tablets produced and successfully passed all quality controls.

2008-2009

Development

Expansion of portfolio to include sterile injectables.

Invested heavily in sterile manufacturing capabilities. Launched the first line of life-saving injectable antibiotics.

2010-2011

R&D Focus

Establishment of dedicated R&D center.

Created a centralized hub for innovation. Hired top talent from leading universities to drive new formulation development.

2012-2013

Market Leadership

Achieved top market share in key therapeutic classes.

Our cardiology portfolio became the market leader. Recognition for excellence in quality and supply chain reliability.

2014

Global Reach

Started exporting to neighboring countries.

First export shipments to Iraq and Afghanistan. Established a dedicated export department.

2015

Innovation

Introduction of novel drug delivery systems.

Launched delayed-release formulations and complex generics, setting a new standard for local manufacturing.

2016-2017

Capacity Building

Major expansion of manufacturing facilities.

Doubled production capacity with a new plant extension. Added automated packaging lines to increase efficiency.

2018-2019

Diversification

Entry into reformulating biotechnology products.

Strategic partnership to develop biosimilars. Investing in the future of personalized medicine.

2018-2024

Resilience & Growth

Continued growth despite global challenges.

Navigated supply chain disruptions successfully. Launched 20+ new products during this period.

2021-2025

Future Vision

Focus on Ronacare and advanced healthcare solutions.

Establishing Ronacare as a premier brand for consumer health. Committing to sustainable practices and expanding our global footprint.